In Vitro Biocompatibility of the Novel Ceramic Composite Baghdadite for Defect Augmentation in Revision Total Hip Arthroplasty.
Baghdadite
MG-63
THP-1
ceramic bone substitute
cytotoxicity
inflammation
revision total hip arthroplasty
Journal
Journal of functional biomaterials
ISSN: 2079-4983
Titre abrégé: J Funct Biomater
Pays: Switzerland
ID NLM: 101570734
Informations de publication
Date de publication:
15 Oct 2023
15 Oct 2023
Historique:
received:
02
09
2023
revised:
03
10
2023
accepted:
11
10
2023
medline:
27
10
2023
pubmed:
27
10
2023
entrez:
27
10
2023
Statut:
epublish
Résumé
Biological augmentation of bony defects in weight-bearing areas of both the acetabulum and the femur remains challenging. The calcium-silicate-based ceramic Baghdadite is a very interesting material to be used in the field of revision total hip arthroplasty for the treatment of bony defects in weight-bearing and non-weight-bearing areas alike. The aim of this study was to investigate the biocompatibility of Baghdadite utilizing an osteoblast-like, human osteosarcoma cell line (MG-63) and the human monocytic leukemia-derived cell line (THP-1). THP-1-derived macrophages and MG-63 were indirectly exposed to Baghdadite for 7 days using a transwell system. Viability was assessed with MTT assay and pH analysis. To investigate proliferation rate, both cell lines were labelled using CFSE and flow cytometrically analyzed. ELISA was used to measure the secretion of IL-1ß, IL-6 and TNFα. The investigation of viability, while showing a slight difference in optical density for the MTT assays in MG-63 cells, did not present a meaningful difference between groups for both cell lines. The comparison of pH and the proportion of living cells between groups did not present with a significant difference for both THP-1 and MG-63. Baghdadite did not have a relevant impact on the proliferation rate of the investigated cell lines. Mean fluorescence intensity was calculated between groups with no significant difference. Baghdadite exerted a proinflammatory effect, which could be seen in an upregulated production of TNFα in macrophages. Production of IL-1ß and IL-6 was not statistically significant, but the IL-6 ELISA showed a trend to an upregulated production as well. A similar effect on MG-63 was not observed. No relevant cytotoxicity of Baghdadite ceramics was encountered. Baghdadite ceramics exhibit a proinflammatory potential by significantly increasing the secretion of TNFα in THP-1-derived macrophages. Whether this proinflammatory potential results in a clinically relevant effect on osteointegration is unclear and requires further investigation. Baghdadite ceramics provide an interesting alternative to conventional bone substitutes and should be further investigated in a biomechanical and in vivo setting.
Identifiants
pubmed: 37888182
pii: jfb14100517
doi: 10.3390/jfb14100517
pmc: PMC10607879
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Peter Brehm GmbH
ID : N/A
Références
Cytokine. 2021 Oct;146:155655
pubmed: 34332274
Orthopade. 2017 Feb;46(2):158-167
pubmed: 28074234
J Biomed Mater Res A. 2012 Sep;100(9):2269-77
pubmed: 22499392
Am J Transl Res. 2022 Oct 15;14(10):7080-7089
pubmed: 36398241
J Arthroplasty. 2020 Jun;35(6S):S79-S85
pubmed: 32151524
Arch Orthop Trauma Surg. 2014 Aug;134(8):1167-73
pubmed: 24840037
Arch Orthop Trauma Surg. 2023 Mar;143(3):1163-1174
pubmed: 34636979
Tissue Eng Part A. 2014 Mar;20(5-6):992-1002
pubmed: 24195838
Materials (Basel). 2017 Feb 10;10(2):
pubmed: 28772513
J Bone Joint Surg Am. 1990 Dec;72(10):1536-40
pubmed: 2254363
Biomater Sci. 2013 Mar 4;1(3):254-256
pubmed: 32481850
Acta Biomater. 2012 Nov;8(11):4162-72
pubmed: 22842031
J Mater Chem B. 2014 Nov 14;2(42):7272-7306
pubmed: 32261954
Acta Biomater. 2021 Oct 1;133:46-57
pubmed: 33974949
J Bone Joint Surg Br. 1996 Mar;78(2):270-5
pubmed: 8666640
J Arthroplasty. 1993 Aug;8(4):341-6
pubmed: 8409985
Nat Protoc. 2016 Oct;11(10):1775-81
pubmed: 27583639
Mater Today Bio. 2022 Oct 25;17:100473
pubmed: 36345364
J Clin Med. 2019 Dec 01;8(12):
pubmed: 31805704
Acta Biomater. 2008 Sep;4(5):1487-97
pubmed: 18501689
Cell Mol Immunol. 2017 Jan;14(1):118-126
pubmed: 26996064
Mediators Inflamm. 2020 Dec 3;2020:3824593
pubmed: 33343230
Biomaterials. 2008 Nov;29(33):4392-402
pubmed: 18757093
Acta Orthop. 2018 Jun;89(3):302-307
pubmed: 29635970
Adv Healthc Mater. 2018 Aug;7(15):e1800218
pubmed: 29877058
Acta Biomater. 2021 Sep 15;132:217-226
pubmed: 33711527
Arch Orthop Trauma Surg. 2020 Jun;140(6):815-825
pubmed: 32100108
Heliyon. 2023 Aug 02;9(8):e18835
pubmed: 37576247
J Mech Behav Biomed Mater. 2014 Jun;34:294-301
pubmed: 24657744
Tissue Eng Part A. 2022 Jun;28(11-12):461-477
pubmed: 35107351